Series of Structured Stages - HEALTH TECHNOLOGY ASSESSMENT - Health Care Assignment

Internal Code: MAS5870

HEALTH TECHNOLOGY ASSESSMENT

Questions: A) Calculate the ICER of the new test relative to the current test in this high-risk population of women. B) Why do you think the cost-effectiveness of the new test is sensitive to prevalent risk of cervical cancer in the population? C) In the original model (prevalence = 0.001), we assumed a 20 min GP appointment costs $35. However, an audit of General Practices conducting the new test shows that 90% of GPs charge patients a double appointment (2x20mins). How does this change your ICER? Explain your answer. D) Is the model sensitive to any other parameters?